Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Change in Accured Expenses: 2016-2021

Historic Change in Accured Expenses for Arcus Biosciences (RCUS) over the last 6 years, with Dec 2021 value amounting to $10.1 million.

  • Arcus Biosciences' Change in Accured Expenses rose 169.22% to $23.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $4.2 million, marking a year-over-year decrease of 54.35%. This contributed to the annual value of $10.1 million for FY2021, which is 26.19% down from last year.
  • Latest data reveals that Arcus Biosciences reported Change in Accured Expenses of $10.1 million as of FY2021, which was down 26.19% from $13.7 million recorded in FY2020.
  • Over the past 5 years, Arcus Biosciences' Change in Accured Expenses peaked at $13.7 million during FY2020, and registered a low of $1.6 million during FY2017.
  • Its 3-year average for Change in Accured Expenses is $8.5 million, with a median of $10.1 million in 2021.
  • Per our database at Business Quant, Arcus Biosciences' Change in Accured Expenses spiked by 682.18% in 2020 and then declined by 26.19% in 2021.
  • Over the past 5 years, Arcus Biosciences' Change in Accured Expenses (Yearly) stood at $1.6 million in 2017, then increased by 18.46% to $1.9 million in 2018, then dropped by 6.30% to $1.8 million in 2019, then surged by 682.18% to $13.7 million in 2020, then dropped by 26.19% to $10.1 million in 2021.